Gilead Sciences (NASDAQ:GILD) reported its Q4 earnings results on Tuesday, February 1, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Gilead Sciences missed estimated earnings by 56.33%, reporting an EPS of $0.69 versus an estimate of $1.58, which surprised analysts.
Revenue was up $177.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.91, which was followed by a 3.65% drop in the share price the next day.
Here’s a look at Gilead Sciences’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 1.74 | 1.73 | 2.09 | 2.15 |
| EPS Actual | 2.65 | 1.87 | 2.08 | 2.19 |
| Revenue Estimate | 6.25B | 6.07B | 6.74B | 7.33B |
| Revenue Actual | 7.42B | 6.22B | 6.42B | 7.42B |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
